|
ATP6V1B2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.13960000000824E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.681600E-03 |
| Normal-vs-Stage2 |
7.236500E-03 |
| Normal-vs-Stage3 |
6.42359999969422E-07 |
| Normal-vs-Stage4 |
1.52343999999527E-05 |
| Stage1-vs-Stage2 |
3.699200E-01 |
| Stage1-vs-Stage3 |
2.807900E-04 |
| Stage1-vs-Stage4 |
4.503700E-03 |
| Stage2-vs-Stage3 |
2.103600E-01 |
| Stage2-vs-Stage4 |
3.069400E-01 |
| Stage3-vs-Stage4 |
8.229200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.7702999999546E-06 |
| Normal-vs-AfricanAmerican |
7.303500E-03 |
| Normal-vs-Asian |
2.936200E-01 |
| Caucasian-vs-AfricanAmerican |
8.364800E-01 |
| Caucasian-vs-Asian |
6.748800E-01 |
| AfricanAmerican-vs-Asian |
7.829800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.589900000045E-06 |
| Normal-vs-Female |
1.541630E-02 |
| Male-vs-Female |
9.606200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.990200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.040540E-04 |
| Normal-vs-Age(61-80Yrs) |
1.59560000001502E-06 |
| Normal-vs-Age(81-100Yrs) |
8.689600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.134000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.417000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.622400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.157800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.172600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.626800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.795600E-01 |
| Normal-vs-Grade 2 |
2.505000E-03 |
| Normal-vs-Grade 3 |
1.76026999999523E-05 |
| Normal-vs-Grade 4 |
1.06500000041088E-07 |
| Grade 1-vs-Grade 2 |
1.159210E-01 |
| Grade 1-vs-Grade 3 |
2.076100E-02 |
| Grade 1-vs-Grade 4 |
4.151700E-04 |
| Grade 2-vs-Grade 3 |
6.345900E-02 |
| Grade 2-vs-Grade 4 |
8.3935000000035E-05 |
| Grade 3-vs-Grade 4 |
1.946000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.141590E-01 |
| Normal-vs-ccB subtype |
7.47240003207139E-09 |
| ccA subtype-vs-ccB subtype |
7.37169991715803E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.039400E-04 |
| Normal-vs-N1 |
1.446360E-01 |
| N0-vs-N1 |
7.771400E-01 |
|
|
